Raymond James & Associates’s Akoustis Technologies Inc AKTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-21,316
Closed -$2.81K 4126
2024
Q2
$2.81K Hold
21,316
﹤0.01% 3948
2024
Q1
$12.6K Sell
21,316
-75
-0.4% -$48 ﹤0.01% 3894
2023
Q4
$17.8K Buy
21,391
+10,000
+88% +$6.72K ﹤0.01% 3774
2023
Q3
$8.58K Buy
+11,391
New +$21K ﹤0.01% 3769
2022
Q1
Sell
-26,269
Closed -$175K 4303
2021
Q4
$175K Buy
+26,269
New +$196K ﹤0.01% 3740
2021
Q2
Sell
-24,722
Closed -$330K 4236
2021
Q1
$330K Buy
+24,722
New +$359K ﹤0.01% 3294
2020
Q4
Sell
-28,900
Closed -$236K 3895
2020
Q3
$236K Buy
+28,900
New +$234K ﹤0.01% 3103
2020
Q2
Sell
-18,600
Closed -$100K 3682
2020
Q1
$100K Buy
+18,600
New +$131K ﹤0.01% 3221

Other funds holding AKTS

Raymond James & Associates's AKTS Position: Q3 2024 in Review

Raymond James & Associates sold out of Akoustis Technologies Inc (AKTS) in Q3 2024, closing a stake of 21,316 shares — an estimated $2.81K sold.

Raymond James & Associates first reported a position in AKTS in Q1 2020 and held it in 8 quarters. The position peaked at $330K in Q1 2021. 77 funds tracked by Wall St. Rank hold AKTS as of Q3 2024.

  • Raymond James & Associates reported no remaining Akoustis Technologies Inc position as of Q3 2024 after selling out during the quarter.
  • Raymond James & Associates sold 21,316 Akoustis Technologies Inc shares in Q3 2024, an estimated $2.81K.
  • Raymond James & Associates first reported a position in Akoustis Technologies Inc in Q1 2020 and held it in 8 quarters.
  • Raymond James & Associates's Akoustis Technologies Inc position peaked at $330K in Q1 2021.
  • 77 funds tracked by Wall St. Rank held Akoustis Technologies Inc as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.